大量放腹腔积液加白蛋白治疗肝硬化张力性腹腔积液的临床效果

刘生水

（陕西省商洛市中心医院感染性疾病科，陕西 商洛，726000）

浏览次数：119次 下载次数：342次

摘要：

目的 评价大量放腹腔积液加白蛋白治疗肝硬化张力性腹腔积液的临床效果。方法 将我院2015年10月至2016年10月收治的66例肝硬化张力性腹腔积液患者随机分为对照组（常规治疗）及观察组（常规治疗基础上进行大量放腹腔积液加 白蛋白治疗），各33 例，比较两组临床疗效。结果 观察组并发症总发生率为9.09%，明显低于对照组的24.24%（P<0.05）。观察组 生活质量各项评分及总分均高于对照组（P<0.05）。治疗后，两组血肌酐、血钠水平均改善，且观察组优于对照组（P<0.05）。结论 大量放腹腔积液加白蛋白治疗肝硬化张力性腹腔积液效果理想，可作为优选治疗方案。

关键词：腹腔积液；白蛋白；肝硬化张力性腹腔积液

中图分类号：R575.2文献标志码：A文章编号：2096-1413(2017)32-0052-02

Clinical effect of large amount of peritoneal effusion albumin in cirrhotic patients with tension pleural effusion
LIU Sheng-shui
(Department of Infectious Diseases, Shangluo Central Hospital, Shangluo 726000, China)

ABSTRACT: Objective To evaluate the clinical effect of large amoun t of ascorbic effusion plus albumin in cirrhotic patients with tension pleural effusion. Methods Sixty-six patients with cirrhotic tension peritoneal effusion who treated in our hospital from October 2015 to October 2016 were randomly divided into control group (routine treatment) and observation group (large amount of ascites fluid plus albumin treatment on the basis of the routine treatment), with 33 cases in each group. The clinical efficacy were compared between the two groups. Results The overall incidence rate of complications in the observation group was 9.09%, which was significantly lower than 24.24% in the control group (P<0.05). The each indexes scores and total scores of the quality of life in the observation group were higher than those in the control group (P<0.05). After treatment, the levels of serum creatinine and serum sodium significantly improved in both groups, and those in the observation group were better than the control group (P<0.05). Conclusion Large amount of peritoneal effusion plus albumin is effective in cirrhotic patients with tension pleural effusion, which can be used as a preferred treatment.
KEYWORDS: peritoneal effusion; albumin; cirrhotic patients with tension pleural effusion

参考文献：
[1] 文川元,朱建新.小剂量呋塞米持续静脉泵入联合小剂量甘露醇治 疗难治性肝硬化腹腔积液的疗效观察[J].临床合理用药杂志,2014,7(6):116-117.
[2] 秦叔逵,刘秀峰,马军,等.注射用重组改构人肿瘤坏死因子治疗国 人恶性胸、腹腔积液的前瞻性多中心临床研究[J].临床肿瘤学杂志,2016,21(7):577-584.
[3] 赵明志,牛卫理.腹腔积液浓缩腹腔回输技术联合奥曲肽治疗肝硬 化顽固性腹腔积液37 例临床疗效观察[J].中国煤炭工业医学杂志,2015,18(2):196-199.
[4] 李珊珊,黄芩,胡月新,等.人血白蛋白在类肺炎性胸腔积液联合治 疗中的临床应用[J].临床医学研究与实践,2016,1(13):46-47.
[5] 徐峰.大量放腹腔积液加白蛋白治疗肝硬化张力性腹腔积液患者 的疗效[J].医疗装备,2017,31(2):131-132.